Canlyniadau Chwilio

Multicolor-FICTION gan José I. Martı́n-Subero, Ilse Chudoba, Lana Harder, Stefan Gesk, W. Grote, Francisco J. Novo, Marı́a José Calasanz, Reiner Siebert

Cael y testun llawn Cael y testun llawn

Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy gan Yanbin Wu, Zhijian Ye, Sou-ming QIN, Cong Wu, Yiqiang Chen, Huan‐Zhong Shi

Cael y testun llawn

ecancermedicalscience gan Marcus Paulo Fernandes Amarante, Riad Naim Younes, Letícia Rigo, Marcelo Rocha Cruz

Cael y testun llawn Cael y testun llawn

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphoma gan Daruka Mahadevan, Joseph M. Unger, Catherine Spier, Daniel O. Persky, Fay Young, Michael LeBlanc, Richard I. Fisher, Thomas P. Miller

Cael y testun llawn Cael y testun llawn

Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK gan Marius Grzelinski, Florian Steinberg, Tobias Martens, Frank Czubayko, Katrin Lamszus, Achim Aigner

Cael y testun llawn

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome gan Hervé Tilly, Philippe Gaulard, Éric Lepage, Charles Dumontet, J Diébold, Isabelle Plantier, Françoise Berger, Michel Symann, Tony Petrella, P Lederlin, Josette Brière

Cael y testun llawn Cael y testun llawn

A novel <i>KIF5B‐ALK</i> variant in nonsmall cell lung cancer gan Daisy Wing‐Sze Wong, Elaine Lai‐Han Leung, Sunny Kit‐Man Wong, Vicky Pui‐Chi Tin, Alan Dart‐Loon Sihoe, Lik‐Cheung Cheng, Joseph S. K. Au, Lap‐Ping Chung, Maria Pik Wong

Cael y testun llawn Cael y testun llawn

A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation gan Georges Delsol, Laurence Lamant, Bernard Mariamé, Karen Pulford, Nicole Dastugue, Pierre Brousset, Françoise Rigal‐Huguet, Talal Al Saati, Douglas Pat Cerretti, Stephan W. Morris, David Y. Mason

Cael y testun llawn Cael y testun llawn

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models gan Helen Y. Zou, Luc Friboulet, David P. Kodack, Lars D. Engstrom, Qiuhua Li, Melissa West, Ruth W. Tang, Hui Wang, Konstantinos Tsaparikos, Jinwei Wang, Sergei Timofeevski, Ryohei Katayama, Dac M. Dinh, Hieu Lam, Justine L. Lam, Shinji Yamazaki, Wenyue Hu, Bhushankumar Patel, Divya Bezwada, Rosa L. Frias, Eugene Lifshits, Sidra Mahmood, Justin F. Gainor, Timothy Affolter, Patrick B. Lappin, Hovhannes J. Gukasyan, Nathan Lee, Shibing Deng, Rakesh K. Jain, Ted W. Johnson, Alice T. Shaw, Valeria R. Fantin, Tod Smeal

Cael y testun llawn Cael y testun llawn

Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer gan Andrew Weickhardt, Micol S. Rothman, Smita Salian‐Mehta, Katja Kiseljak‐Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

Cael y testun llawn Cael y testun llawn

Heart rate decrease during crizotinib treatment and potential correlation to clinical response gan Sai‐Hong Ignatius Ou, Wilson P. Tong, Michele C. Azada, Christina T. Siwak-Tapp, Joni Dy, Jonathan A. Stiber

Cael y testun llawn Cael y testun llawn

The role of indwelling pleural catheter in management of malignant pleural effusion: A creative new technique for an old method gan FilipeMoreira de Andrade

Cael y testun llawn

Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice gan Martin U. Kuefer, A. Thomas Look, Karen Pulford, Frederick G. Behm, Paul K. Pattengale, David Y. Mason, Stephan W. Morris

Cael y testun llawn Cael y testun llawn

The use of stained cytologic direct smears for <i>ALK</i> gene rearrangement analysis of lung adenocarcinoma gan Bryan L. Betz, Catherine A. Dixon, Helmut C. Weigelin, Stewart M. Knoepp, Michael H. Roh

Cael y testun llawn Cael y testun llawn

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options gan Conor Steuer, Suresh S. Ramalingam

Cael y testun llawn Cael y testun llawn

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer gan Jun Ho Ji, Young Lyun Oh, Min Eui Hong, Jae Won Yun, Hyunwoo Lee, Kim DeokGeun, Yongick Ji, Kim Duk-Hwan, Woong‐Yang Park, Hyun‐Tae Shin, Kyoung‐Mee Kim, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

Cael y testun llawn Cael y testun llawn

Identification of anaplastic lymphoma kinase fusions in renal cancer gan Emiko Sugawara, Yuki Togashi, Naoto Kuroda, Seiji Sakata, Satoko Hatano, Reimi Asaka, Takeshi Yuasa, Junji Yonese, Masanobu Kitagawa, Hiroyuki Mano, Yuichi Ishikawa, Kengo Takeuchi

Cael y testun llawn Cael y testun llawn

Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1 gan Karen Pulford, Laurence Lamant, Stephan W. Morris, Lisa H. Butler, Katrina Wood, David A. Stroud, Georges Delsol, David Y. Mason

Cael y testun llawn

Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data gan Gouji Toyokawa, Takashi Seto

Cael y testun llawn Cael y testun llawn

ALK-rearrangements and testing methods in non-small cell lung cancer: a review gan Rodney E. Shackelford, Moiz Vora, Kim Mayhall, James D. Cotelingam

Cael y testun llawn Cael y testun llawn